- Home
- VRDN vs ASM Comparison
VRDN vs ASM Comparison
Compare VRDN & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | ASM |
|---|---|---|
| Founded | 2006 | 1968 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2014 | 2005 |
Fundamental Metrics
Financial Performance| Metric | VRDN | ASM |
|---|---|---|
| Price | $16.25 | $6.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $35.46 | $8.18 |
| AVG Volume (30 Days) | 3.2M | ★ 4.2M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | $13.73 | $53.35 |
| Revenue Next Year | $279.00 | $34.26 |
| P/E Ratio | ★ N/A | $67.93 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.18 | $3.10 |
| 52 Week High | $34.29 | $11.99 |
Technical Indicators
Market Signals| Indicator | VRDN | ASM |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 48.55 |
| Support Level | $15.65 | $6.07 |
| Resistance Level | $18.05 | $8.12 |
| Average True Range (ATR) | 0.83 | 0.42 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 23.73 | 29.44 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.